Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)

v3.24.2.u1
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Operating expenses:        
Research and development $ 1,130,978 $ 1,594,713 $ 2,097,088 $ 3,248,082
General and administrative 657,806 733,496 1,415,087 1,605,171
Total operating expenses 1,788,784 2,328,209 3,512,175 4,853,253
Loss from operations (1,788,784) (2,328,209) (3,512,175) (4,853,253)
Interest income 73,475 128,218 155,640 218,706
Net loss (1,715,309) (2,199,991) (3,356,535) (4,634,547)
Other comprehensive income (loss):        
Foreign currency translation gain (loss) 1,583 (4,385) 748 (15,184)
Unrealized gain (loss) on investments 2,444 (20,180) 21,642 13,464
Comprehensive loss $ (1,711,282) $ (2,224,556) $ (3,334,145) $ (4,636,267)
Net loss per share:        
Basic and diluted (in dollars per share) $ (0.1) $ (0.16) $ (0.2) $ (0.35)
Weighted average shares outstanding:        
Basic and diluted (in shares) 17,514,637 13,420,029 16,747,198 13,263,770